Evidence map›Paper›PMID 39382568›Full record

ArticleeLife2024

Transcriptional responses in a mouse model of silicone wire embolization induced acute retinal artery ischemia and reperfusion.

Yuedan Wang, Ying Li, Jiaqing Feng, Chuansen Wang, Yuwei Wan, Bingyang Lv, Yinming Li, Hao Xie, Ting Chen, Faxi Wang and 3 more

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuedan Wang *Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
Ying Li *Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
Jiaqing Feng *Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.ORCID https://orcid.org/0000-0003-0514-4663
Chuansen WangDepartment of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
Yuwei WanDepartment of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
Bingyang LvDepartment of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
Yinming LiDepartment of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
Hao XieDepartment of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
Ting ChenDepartment of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
Faxi WangDepartment of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
Ziyue LiDepartment of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.ORCID https://orcid.org/0000-0002-7393-1442
Anhuai YangDepartment of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
Xuan XiaoDepartment of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.ORCID https://orcid.org/0000-0001-7762-8689

Funding

Fundamental Research Funds for the Central Universities 2042023gf0013Key research and development project of Hubei Province 2022BCA009National Key R&D Program of China 2023YFC2308404National Nature Science Foundation of China 82371079
6 · The paper itself

Abstract

Acute retinal ischemia and ischemia-reperfusion injury are the primary causes of retinal neural cell death and vision loss in retinal artery occlusion (RAO). The absence of an accurate mouse model for simulating the retinal ischemic process has hindered progress in developing neuroprotective agents for RAO. We developed a unilateral pterygopalatine ophthalmic artery occlusion (UPOAO) mouse model using silicone wire embolization combined with carotid artery ligation. The survival of retinal ganglion cells and visual function were evaluated to determine the duration of ischemia. Immunofluorescence staining, optical coherence tomography, and haematoxylin and eosin staining were utilized to assess changes in major neural cell classes and retinal structure degeneration at two reperfusion durations. Transcriptomics was employed to investigate alterations in the pathological process of UPOAO following ischemia and reperfusion, highlighting transcriptomic differences between UPOAO and other retinal ischemia-reperfusion models. The UPOAO model successfully replicated the acute interruption of retinal blood supply observed in RAO. 60 min of Ischemia led to significant loss of major retinal neural cells and visual function impairment. Notable thinning of the inner retinal layer, especially the ganglion cell layer, was evident post-UPOAO. Temporal transcriptome analysis revealed various pathophysiological processes related to immune cell migration, oxidative stress, and immune inflammation during the non-reperfusion and reperfusion periods. A pronounced increase in microglia within the retina and peripheral leukocytes accessing the retina was observed during reperfusion periods. Comparison of differentially expressed genes (DEGs) between the UPOAO and high intraocular pressure models revealed specific enrichments in lipid and steroid metabolism-related genes in the UPOAO model. The UPOAO model emerges as a novel tool for screening pathogenic genes and promoting further therapeutic research in RAO.

Indexed as

Disease Models, AnimalReperfusion InjuryAnimalsIschemiaMaleMiceMice, Inbred C57BLRetinaRetinal ArteryRetinal Artery OcclusionRetinal Ganglion CellsTranscriptomeimmune cellimmunologyinflammationischemiamousemouse modelneurosciencereperfusion injuryretinal artery occlusiontranscriptomics

Identifiers

PMID39382568
PMCPMC11464005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.